Subject: Smallcap Discoveries: ImmunoPrecise Antibodies (NASDAQ: IPA) Update with CEO Jennifer Bath

ImmunoPrecise Antibodies (NASDAQ: IPA) Update with CEO Jennifer Bath
On April 19th we had an update with CEO Jennifer Bath from ImmunoPrecise Antibodies.

ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd. is a biotherapeutic, innovation-powered company that supports its business partners in their quest to discover and develop novel antibodies against a broad range of target classes and diseases. The Company offers a hybrid of services and programs with advanced platforms and technologies — dynamic scientists and business advisors — to optimize antibody discovery and development, against rare and/or challenging epitopes. For further information, visit www.immunoprecise.com.

Video Interview:
After our interviews, we host a Free-For-All session with the live participants to review all things Smallcap Discoveries is following, including updates and commentary companies from both the Select Portfolio and Select Watchlist. 
86 East 23rd Ave, v5v 1w9, Vancouver, Canada
You may unsubscribe or change your contact details at any time.

Powered by:
GetResponse

    This is an online snapshot of a newsletter created by the owner of Small Cap Premium Service (DJ Dunkerley, 86 East 23rd Ave, v5v 1w9 Vancouver, Canada) and sent via GetResponse on 2022-04-20. Report abuse